|
CA2502479A1
|
|
Laminin receptor binding molecule
|
|
CA2485001A1
|
|
Prostate cancer diagnosis and prognosis
|
|
CA2441695A1
|
|
Regulation of matrix metalloproteinases by psp94 family members
|
|
CA2426589A1
|
|
Psp94 diagnostic reagents and assays
|
|
CA2411729A1
|
|
Knock-in mouse prostate cancer model
|
|
CA2407548A1
|
|
Psp94: use for treatment of hypercalcemia and bone metastasis
|
|
CA2396891A1
|
|
Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
|
|
CA2391438A1
|
|
Psp94 diagnostic reagents and assays
|
|
CA2380662A1
|
|
Psp94 diagnostic reagents and assays
|
|
CA2361736A1
|
|
Psp 94: use for treatment of hypercalcemia and bone metastasis
|
|
CA2359650A1
|
|
Pharmaceutical preparations and methods for inhibiting tumors
|
|
CA2357181A1
|
|
Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
|
|
CA2355334A1
|
|
Pharmaceutical preparations and methods for inhibiting tumors
|
|
CA2335773A1
|
|
A method of assessing the biological status of pathology in epithelial tissue
|
|
AU3353701A
|
|
A method of assessing the biological status of pathology in epithelial tissue, especially colon
|
|
CA2321256A1
|
|
Pharmaceutical preparations and methods for inhibiting tumours
|
|
US6107103A
|
|
Assay for PSP94 protein
|
|
GB9612546D0
|
|
Dressing for wound and method of manufacture thereof
|
|
GB9604653D0
|
|
Establishment and characterization of bovine cell lines that consecutively express the early region one gene products
|
|
GB9604714D0
|
|
Recombinant bovine adenovirus vector system and its application in gene therapy and in the development of recombinant vaccine
|
